Cargando…
DUSP5 and DUSP6, two ERK specific phosphatases, are markers of a higher MAPK signaling activation in BRAF mutated thyroid cancers
BACKGROUND: Molecular alterations of the MAPK pathway are frequently observed in papillary thyroid carcinomas (PTCs). It leads to a constitutive activation of the signalling pathway through an increase in MEK and ERK phosphorylation. ERK is negatively feedback-regulated by Dual Specificity Phosphata...
Autores principales: | Buffet, Camille, Hecale-Perlemoine, Karine, Bricaire, Léopoldine, Dumont, Florent, Baudry, Camille, Tissier, Frédérique, Bertherat, Jérôme, Cochand-Priollet, Beatrix, Raffin-Sanson, Marie-Laure, Cormier, Françoise, Groussin, Lionel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599027/ https://www.ncbi.nlm.nih.gov/pubmed/28910386 http://dx.doi.org/10.1371/journal.pone.0184861 |
Ejemplares similares
-
Dual Specificity Phosphatase 5, a Specific Negative Regulator of ERK Signaling, Is Induced by Serum Response Factor and Elk-1 Transcription Factor
por: Buffet, Camille, et al.
Publicado: (2015) -
NF-κB signaling activation and roles in thyroid cancers: implication of MAP3K14/NIK
por: Cormier, Françoise, et al.
Publicado: (2023) -
MET overexpression and activation favors invasiveness in a model of anaplastic thyroid cancer
por: Garcia, Cyril, et al.
Publicado: (2019) -
DUSP5 and DUSP6 modulate corneal epithelial cell proliferation
por: Wang, Zheng, et al.
Publicado: (2010) -
DUSP4 phosphatase puts the brakes on DLBCL
por: Rickert, Robert
Publicado: (2015)